Enterome
Paris, France · Biotechnology, Pharmaceutical, Therapeutics · 135 employees
Enterome is a clinical-stage biopharmaceutical company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. Enterome’s pioneering approach to drug discovery is based on its unique and powerful bacterial Mimicry drug discovery platform, which allows it to analyze and uncover new biological insights from the millions of gut bacterial proteins in constant cr
Funding history
- Funding Round — $19.0M — Jun 2025
Recent signals
- Jun 12, 2025: Raised $19.0M
See plans & pricing → Track Enterome’s funding, hiring, and signals — with verified contacts — on Fundz.